BENEVICH ERIC — SEC insider filings

SEC reporting owner CIK 1643653. 38 insider filings on record with FilingPulse; latest filed 2026-09-15.

Transaction summary — filings shown

Covers all 38 filings on record, filed 2020-08-07 to 2026-09-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
NEUROCRINE BIOSCIENCES INC (NBIX)Chief Commercial Officer35—47 legs · 345,118 sh · $43,726,39877
aTYR PHARMA INC (ATYR)Director3——3

Insider filings — BENEVICH ERIC

FiledFormIssuerReported transactionsSource
2026-09-154NEUROCRINE BIOSCIENCES INC (NBIX)Grant/award (A): 6,275 @ $0 · Tax withholding (F): 3,386 @ $156.22EDGAR
2026-09-104NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 3,194 @ $43.24 · Sale (S): 2,154 @ $154.61 · Option exercise (M): 3,194 (derivative) @ $0EDGAR
2026-05-134aTYR PHARMA INC (ATYR)Grant/award (A): 50,000 (derivative) @ $0EDGAR
2026-02-174NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 2,005 @ $0 · Tax withholding (F): 1,082 @ $123.10 · Option exercise (M): 1,961 @ $0 · Tax withholding (F): 1,058 @ $124.12 · Option exercise (M): 2,083 @ $0 · Tax withholding (F): 1,124 @ $124.12 · +7 moreEDGAR
2026-02-034NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 2,294 @ $0 · Tax withholding (F): 1,292 @ $136.06 · Option exercise (M): 2,294 (derivative) @ $0EDGAR
2026-01-164/ANEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 12,830 @ $35.99 · Option exercise (M): 12,830 (derivative) @ $0EDGAR
2025-12-024NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 5,970 @ $35.99 · Sale (S): 5,970 @ $151.74 · Option exercise (M): 5,970 (derivative) @ $0EDGAR
2025-05-024aTYR PHARMA INC (ATYR)Grant/award (A): 50,000 (derivative) @ $0EDGAR
2025-02-144NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 2,083 @ $0 · Sale (S): 1,098 @ $116.74 · Option exercise (M): 1,961 @ $0 · Sale (S): 1,056 @ $116.71 · Grant/award (A): 42,805 (derivative) @ $0 · Grant/award (A): 8,022 (derivative) @ $0 · +2 moreEDGAR
2025-02-124NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 1,860 @ $0 · Sale (S): 980 @ $118.31 · Option exercise (M): 1,860 (derivative) @ $0EDGAR
2025-02-044NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 2,294 @ $0 · Sale (S): 1,207 @ $152.94 · Option exercise (M): 2,294 (derivative) @ $0EDGAR
2024-12-124aTYR PHARMA INC (ATYR)Grant/award (A): 100,000 (derivative) @ $0EDGAR
2024-04-174NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 7,231 @ $81.49 · Sale (S): 7,231 @ $133.36 · Option exercise (M): 12,587 @ $81.05 · Sale (S): 12,587 @ $133.36 · Option exercise (M): 7,231 (derivative) @ $81.49 · Option exercise (M): 12,587 (derivative) @ $81.05EDGAR
2024-03-154NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 5,479 @ $79.02 · Sale (S): 5,479 @ $139.38 · Option exercise (M): 69,521 @ $81.05 · Sale (S): 69,521 @ $139.38 · Option exercise (M): 5,479 (derivative) @ $79.02 · Option exercise (M): 69,521 (derivative) @ $81.05EDGAR
2024-02-294NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 53,143 @ $43.24 · Sale (S): 53,143 @ $134.69 · Option exercise (M): 21,857 @ $79.02 · Sale (S): 21,857 @ $134.69 · Option exercise (M): 53,143 (derivative) @ $43.24 · Option exercise (M): 21,857 (derivative) @ $79.02EDGAR
2024-02-154NEUROCRINE BIOSCIENCES INC (NBIX)Sale (S): 1,098 @ $133.01 · Grant/award (A): 39,426 (derivative) @ $0 · Grant/award (A): 7,846 (derivative) @ $0EDGAR
2024-02-084NEUROCRINE BIOSCIENCES INC (NBIX)Sale (S): 1,280 @ $142.12 · Sale (S): 980 @ $134.19EDGAR
2024-02-024NEUROCRINE BIOSCIENCES INC (NBIX)Sale (S): 1,207 @ $140.78EDGAR
2023-08-234NEUROCRINE BIOSCIENCES INC (NBIX)Sale (S): 1,600 @ $107.40EDGAR
2023-05-114/ANEUROCRINE BIOSCIENCES INC (NBIX)Holdings only — no transactions reportedEDGAR
2023-05-114/ANEUROCRINE BIOSCIENCES INC (NBIX)Holdings only — no transactions reportedEDGAR
2023-02-154NEUROCRINE BIOSCIENCES INC (NBIX)Grant/award (A): 51,782 (derivative) @ $0 · Grant/award (A): 8,332 (derivative) @ $0EDGAR
2023-02-084NEUROCRINE BIOSCIENCES INC (NBIX)Sale (S): 1,280 @ $105.63 · Sale (S): 2,030 @ $102.29 · Sale (S): 15,360 @ $102.42 · Sale (S): 980 @ $104.12EDGAR
2023-02-024NEUROCRINE BIOSCIENCES INC (NBIX)Sale (S): 1,207 @ $109.95EDGAR
2023-01-104NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 400 @ $43.24 · Sale (S): 400 @ $125 · Option exercise (M): 400 (derivative) @ $43.24EDGAR
2022-12-014NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 22,162 @ $41.78 · Sale (S): 22,162 @ $125.90 · Option exercise (M): 7,775 @ $35.99 · Sale (S): 7,775 @ $125.90 · Option exercise (M): 20,063 @ $43.24 · Sale (S): 20,063 @ $125.90 · +3 moreEDGAR
2022-11-104NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 24,593 @ $41.78 · Sale (S): 24,593 @ $125.33 · Option exercise (M): 100 @ $41.78 · Sale (S): 100 @ $125.36 · Option exercise (M): 24,593 (derivative) @ $41.78 · Option exercise (M): 100 (derivative) @ $41.78EDGAR
2022-11-044NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 400 @ $41.78 · Sale (S): 400 @ $125 · Option exercise (M): 8,968 @ $41.78 · Sale (S): 8,968 @ $125.02 · Option exercise (M): 400 (derivative) @ $41.78 · Option exercise (M): 8,968 (derivative) @ $41.78EDGAR
2022-10-194NEUROCRINE BIOSCIENCES INC (NBIX)Sale (S): 4,960 @ $110.82EDGAR
2022-02-094NEUROCRINE BIOSCIENCES INC (NBIX)Sale (S): 809 @ $80.68 · Sale (S): 2,030 @ $80.83 · Sale (S): 1,280 @ $80.78 · Sale (S): 980 @ $79.67EDGAR
2022-02-024NEUROCRINE BIOSCIENCES INC (NBIX)Grant/award (A): 62,483 (derivative) @ $0 · Grant/award (A): 9,175 (derivative) @ $0EDGAR
2021-08-184NEUROCRINE BIOSCIENCES INC (NBIX)Sale (S): 5,628 @ $89.62EDGAR
2021-03-264/ANEUROCRINE BIOSCIENCES INC (NBIX)Grant/award (A): 49,049 (derivative) @ $0EDGAR
2021-02-094NEUROCRINE BIOSCIENCES INC (NBIX)Sale (S): 809 @ $114.03 · Sale (S): 845 @ $116.89 · Sale (S): 1,395 @ $116.76 · Sale (S): 2,030 @ $116.84 · Grant/award (A): 44,632 (derivative) @ $0 · Grant/award (A): 7,439 (derivative) @ $0EDGAR
2021-01-274NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 3,477 @ $41.78 · Sale (S): 3,477 @ $120.03 · Sale (S): 1,600 @ $120.03 · Option exercise (M): 300 @ $41.78 · Sale (S): 300 @ $120 · Sale (S): 100 @ $120 · +2 moreEDGAR
2020-11-164NEUROCRINE BIOSCIENCES INC (NBIX)Sale (S): 2,257 @ $90.71EDGAR
2020-11-044NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 20,595 @ $35.99 · Sale (S): 20,595 @ $96.53 · Option exercise (M): 20,595 (derivative) @ $35.99EDGAR
2020-08-074NEUROCRINE BIOSCIENCES INC (NBIX)Sale (S): 2,257 @ $118.85EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-06 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1643653 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs